Rajesh Krishnan

Insider Reports History

Entity
Individual
Location
12230 El Camino, Suite 300, San Diego, CA
Signature
/s/Chase C. Leavitt, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rajesh Krishnan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oncternal Therapeutics, Inc. CTO/CSO Common Stock 44K $21.8K $0.50 Jan 3, 2024 Direct
Oncternal Therapeutics, Inc. CTO/CSO Stock Option 17.7K Feb 14, 2024 Direct

Insider Reports Filed by Rajesh Krishnan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ONCT Oncternal Therapeutics, Inc. Feb 14, 2024 1 $0 4 Feb 15, 2024 CTO/CSO
ONCT Oncternal Therapeutics, Inc. Jan 3, 2024 1 -$5.87K 4 Jan 5, 2024 Chief Technical Officer
ONCT Oncternal Therapeutics, Inc. Oct 2, 2023 14 $0 4 Oct 4, 2023 Chief Technical Officer
ONCT Oncternal Therapeutics, Inc. Jul 3, 2023 1 -$3.92K 4 Jul 5, 2023 Chief Technology Officer
ONCT Oncternal Therapeutics, Inc. Feb 21, 2023 1 $0 4 Feb 23, 2023 Chief Technology Officer
ONCT Oncternal Therapeutics, Inc. Jan 3, 2023 1 -$6.36K 4 Jan 5, 2023 Chief Technology Officer
ONCT Oncternal Therapeutics, Inc. Jul 28, 2022 2 $0 4 Aug 1, 2022 Chief Technology Officer
ONCT Oncternal Therapeutics, Inc. Jan 20, 2022 1 $0 4 Jan 24, 2022 Chief Technology Officer
ONCT Oncternal Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Chief Technology Officer
ONCT Oncternal Therapeutics, Inc. May 25, 2021 0 $0 3 May 27, 2021 Chief Technology Officer